
Robert Edward Fuller
Examiner (ID: 11117, Phone: (571)272-6300 , Office: P/3676 )
| Most Active Art Unit | 3676 |
| Art Unit(s) | 3672, 3676 |
| Total Applications | 1083 |
| Issued Applications | 812 |
| Pending Applications | 95 |
| Abandoned Applications | 204 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17473970
[patent_doc_number] => 20220081474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => Nucleic Acids for Treatment of Allergies
[patent_app_type] => utility
[patent_app_number] => 17/028762
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/028762 | Nucleic Acids for Treatment of Allergies | Sep 21, 2020 | Pending |
Array
(
[id] => 17830078
[patent_doc_number] => 20220267382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/627212
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627212 | CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME | Sep 17, 2020 | Pending |
Array
(
[id] => 17830078
[patent_doc_number] => 20220267382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/627212
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627212 | CHIMERIC HEMAGGLUTININ PROTEIN AND A VACCINE COMPOSITION COMPRISING THE SAME | Sep 17, 2020 | Pending |
Array
(
[id] => 16710380
[patent_doc_number] => 20210077527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => UNIVERSAL DONOR SELECTION METHOD TO IDENTIFY NK-CELL-DONORS
[patent_app_type] => utility
[patent_app_number] => 17/018681
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018681 | UNIVERSAL DONOR SELECTION METHOD TO IDENTIFY NK-CELL-DONORS | Sep 10, 2020 | Pending |
Array
(
[id] => 16673111
[patent_doc_number] => 20210061874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => CLAUDIN-6 PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/017444
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/017444 | CLAUDIN-6 PEPTIDES | Sep 9, 2020 | Abandoned |
Array
(
[id] => 16657401
[patent_doc_number] => 20210054037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => PEPTIDES OF PAGE5
[patent_app_type] => utility
[patent_app_number] => 17/017457
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/017457 | PEPTIDES OF PAGE5 | Sep 9, 2020 | Abandoned |
Array
(
[id] => 16628731
[patent_doc_number] => 20210047384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => SYNTAC POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/015282
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/015282 | SYNTAC POLYPEPTIDES AND USES THEREOF | Sep 8, 2020 | Pending |
Array
(
[id] => 16657400
[patent_doc_number] => 20210054036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/013228
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013228 | PEPTIDES | Sep 3, 2020 | Abandoned |
Array
(
[id] => 16657409
[patent_doc_number] => 20210054045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/010653
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010653 | PEPTIDES | Sep 1, 2020 | Abandoned |
Array
(
[id] => 16523797
[patent_doc_number] => 20200397877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => ENHANCING T CELL ACTIVATION USING ALTERED MHC-PEPTIDE LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/009613
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/009613 | Enhancing T cell activation using altered MHC-peptide ligands | Aug 31, 2020 | Issued |
Array
(
[id] => 17895437
[patent_doc_number] => 20220305099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/638576
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638576 | METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS | Aug 25, 2020 | Abandoned |
Array
(
[id] => 17895437
[patent_doc_number] => 20220305099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/638576
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638576 | METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS | Aug 25, 2020 | Abandoned |
Array
(
[id] => 17007093
[patent_doc_number] => 20210238254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => SYNTAC POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/001847
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/001847 | SYNTAC POLYPEPTIDES AND USES THEREOF | Aug 24, 2020 | Abandoned |
Array
(
[id] => 16628976
[patent_doc_number] => 20210047629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => PEPTIDES DERIVED FROM KALLIKREIN 4
[patent_app_type] => utility
[patent_app_number] => 16/998945
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998945 | PEPTIDES DERIVED FROM KALLIKREIN 4 | Aug 19, 2020 | Abandoned |
Array
(
[id] => 16673094
[patent_doc_number] => 20210061857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => PEPTIDES FROM PIWIL1
[patent_app_type] => utility
[patent_app_number] => 16/994399
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994399 | PEPTIDES FROM PIWIL1 | Aug 13, 2020 | Abandoned |
Array
(
[id] => 16482492
[patent_doc_number] => 20200376092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => FRAGMENTS OF P97 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/992821
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992821 | FRAGMENTS OF P97 AND USES THEREOF | Aug 12, 2020 | Abandoned |
Array
(
[id] => 20373526
[patent_doc_number] => 12480958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Method for the characterization of peptide:MHC binding polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/990701
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8508
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 292
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990701 | Method for the characterization of peptide:MHC binding polypeptides | Aug 10, 2020 | Issued |
Array
(
[id] => 19586405
[patent_doc_number] => 20240383962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => GENETICALLY ENGINEERED CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/634963
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634963 | GENETICALLY ENGINEERED CELLS AND USES THEREOF | Aug 9, 2020 | Pending |
Array
(
[id] => 19586405
[patent_doc_number] => 20240383962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => GENETICALLY ENGINEERED CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/634963
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634963 | GENETICALLY ENGINEERED CELLS AND USES THEREOF | Aug 9, 2020 | Pending |
Array
(
[id] => 16613648
[patent_doc_number] => 20210032301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/988425
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988425 | PEPTIDES | Aug 6, 2020 | Abandoned |